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Neuronal nAChRs in themedial habenula (MHb) to the interpeduncular nucleus (IPN) pathway are keymediators of nicotine’s aversive
properties. In this paper, we report new details regarding nAChR anatomical localization and function inMHb and IPN. A new group of
knock-inmicewere created that each expresses a single nAChR subunit fused toGFP, allowing high-resolutionmapping.We find that3
and 4 nAChR subunit levels are strong throughout the ventral MHb (MHbV). In contrast, 6, 2, 3, and 4 subunits are selectively
found in some, but not all, areas of MHbV. All subunits were found in both ChAT-positive and ChAT-negative cells in MHbV. Next, we
examined functional properties of neurons in the lateral and central part of MHbV (MHbVL andMHbVC) using brain slice patch-clamp
recordings. MHbVL neurons were more excitable than MHbVC neurons, and they also responded more strongly to puffs of nicotine. In
addition,we studied firing responses ofMHbVLandMHbVCneurons in response tobath-appliednicotine. Cells inMHbVL, butnot those
in MHbVC, increased their firing substantially in response to 1 M nicotine. Additionally, MHbVL neurons from mice that underwent
withdrawal from chronic nicotine were less responsive to nicotine application comparedwithmice withdrawn from chronic saline. Last,
we characterized rostral and dorsomedial IPN neurons that receive input from MHbVL axons. Together, our data provide new details
regarding neurophysiology and nAChR localization and function in cells within the MHbV.
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Introduction
Recently, human genetic studies have uncovered a number of
alleles that confer susceptibility to developing dependence to nic-
otine found in tobacco products (Bierut et al., 2007). The most
striking risk alleles are located within a gene cluster on chromo-
some 15 containing the 3, 4, and 5 nAChR genes (Saccone et
al., 2007, 2009; Bierut et al., 2008). These nAChR subunits, par-
ticularly 3 and 4, exhibit extremely high expression in both
medial habenula (MHb) and interpeduncular nucleus (IPN)
(Dineley-Miller and Patrick, 1992; Marks et al., 1992). Several
rodent studies indicate a key role for 5- and/or 4-containing
nAChRs in modulating nicotine intake. For example, 5 KO
mice consume significantly more nicotine than their 5 WT
counterparts, and reexpression of 5 subunits in MHb of 5 KO
mice restores aversion to high doses of nicotine (Fowler et al.,
2011). In a complementary study, Frahm et al. (2011) found that
overexpression of 4-containing nAChRs in MHb enhances
aversion to, and consequently reduces consumption of, nicotine.
These studies, coupled with recent findings indicating the exis-
tence of distinct neuronal populations in ventral MHb (MHbV)
(Aizawa et al., 2012), point to the need for a better understanding
of nAChR function within specific cell populations in MHbV.
Several nAChR subunits exhibit their highest expression level
in the MHb (Perry et al., 2002). In addition, most nAChR sub-
units found in heteromeric receptors are expressed in MHb
(Dineley-Miller and Patrick, 1992; Marks et al., 1992), which
theoretically increases the number of distinct nAChR subtypes
found in MHb compared with other brain areas. Several studies
have attempted to identify important nAChR subtypes in MHb
neurons. Robin Lester and colleagues identified 34* (* sub-
units in addition to those listed may be found in the indicated
pentameric receptor) nAChRs as the predominant subtype in
MHbV, with a minor contribution from 2* nAChRs in some
cells (Quick et al., 1999). Studies in mice expressing gain-of-
function4 nAChR subunits demonstrated expression and func-
tion of 4* nAChRs in lateral MHbV neurons (Nashmi et al.,
2007; Fonck et al., 2009).
Because of the small size of the MHb, prior studies using ra-
dioligand binding or mRNA in situ hybridization did not allow
for high-resolution mapping of nAChR subunit localization in
specific cell types within this brain area. Although basic electro-
physiological features of MHb neurons are starting to be uncov-
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ered (Kim and Chang, 2005), we fail to understand how
activation ofMHb nAChRs changes excitability of the neurons in
which they reside and the circuits into which they are integrated.
To address these shortcomings in our understanding of MHb
nAChR function, we combined immunohistochemistry with
brain slice patch-clamp electrophysiology using mouse models.
We generated knock-in mouse strains expressing 3, 4, 2, 3,
and 4 nAChR subunits fused to GFP. Along with previously
generated 6-GFP mice (Mackey et al., 2012), we localized six
nAChR subunits in specific regions of MHb and IPN. Further, in
recordings from MHb and IPN neurons in brain slices from
C57BL/6WTmice, we identified neuronal cell types that differ in
their sensitivity to nicotine.
Materials andMethods
Materials. CNQX and picrotoxin were purchased from Tocris Biosci-
ence, and all other drugs and chemicals not indicated above were pur-
chased from Sigma-Aldrich.
Mice. C57BL/6 mice used for electrophysiology studies were pur-
chased from The Jackson Laboratory. Bacterial artificial chromosome
(BAC) transgenicmice expressingGFP-labeled6 nAChR subunits were
described previously (Mackey et al., 2012). Briefly, a BAC containing the
6 nAChR subunit gene was modified by recombineering to introduce a
GFP sequence in-frame into the M3-M4 portion of the 6 open reading
frame. This modified BACwas used to produce transgenic mice. In these
mice, 6 nAChRs exhibit normal distribution in the brain, normal ex-
pression levels, and normal function (Mackey et al., 2012; Henderson et
al., 2014). All groups of mice used in this study had approximately equal
numbers ofmales and females. All mice were between 8 and 14 weeks old
when experiments were conducted.
Construction and testing of GFP-labeled 3 and 4 nAChR subunits.
Mouse 3 and 4 nAChR cDNAs in pCDNA3.1 were a generous gift
from Jerry Stitzel (Institute for Behavioral Genetics, University of Colo-
rado, Boulder, CO). GFP was inserted in-frame into the M3-M4 loop
region of the 3 and 4 nAChR subunit coding sequence. This insertion
site yields normal, functional receptors when GFP (or similar fluoro-
phore such as YFP orCFP) is inserted into4 (Nashmi et al., 2003, 2007),
6 (Drenan et al., 2008a; Xiao et al., 2011; Mackey et al., 2012), 2
(Nashmi et al., 2003), and 3 (Drenan et al., 2008a) nAChR subunits.
GFP insertion was executed using a modified, two-step QuikChange
(Stratagene) reaction according to our previously published methods
(Drenan et al., 2008a). Briefly, an Ala-Gly-Ala linker was inserted imme-
diately 5 and 3 to the GFP coding sequence. AlaGlyAla-GFP-AlaGlyAla
was inserted between residues Gly373 and Ala374 in mouse 3 and be-
tween residues Gly378 and Pro379 in mouse 4. All DNA constructs
were fully sequenced before use.
To verify that GFP-labeled 3 and 4 nAChR subunits were func-
tional, two-electrode voltage clamp in Xenopus laevis oocytes was con-
ducted as previously described for other GFP-labeled nAChR subunits
(Drenan et al., 2008a). Briefly, constructs were linearized and cRNA was
produced using a T7 in vitro transcription kit (mMessage mMachine;
Ambion). RNA yield was quantified with absorbance at 260 nm. High-
qualityWTorGFP3:4 cRNAwas injected at a ratio of 2:3 bymass into
stage V to VIX. laevis oocytes. After injection, oocytes were incubated for
1–4 d in ND-96 buffer (in mM: 96 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, and 5
HEPES/NaOH, pH 7.6) supplemented with 50 g/ml gentamycin and
2.5 mM sodium pyruvate. Two-electrode voltage clamp was performed
using anOpusXpress 6000A (Molecular Devices). Oocytes were clamped
at a holding potential of 60 mV; 1 ml of ND-96 solution containing
ACh (concentrations indicated in Fig. 1A) was applied to clamped
oocytes for 12 s followed by a 2 min wash with drug-free ND-96. Data
were sampled at 50 Hz and filtered at 20 Hz.
nAChR-GFP knock-in mice. Five additional knock-in mouse strains
were generated and studied in this project, as summarized in Figure 1.
These nAChR-GFP subunits were designed to insert a monomeric en-
hanced GFP (called here simply GFP) in-frame into theM3-M4 intracel-
lular loop. The 4-GFP knock-in strain was constructed, bred, and
backcrossed to C57BL/6 at Caltech (4 generations) using procedures
previously used to generate mice with yellow fluorescent protein (YFP)-
tagged 4 subunits (Nashmi et al., 2007). Four strains were produced by
genOway for the3,2,3, and4 nAChR subunits. The exact insertion
site of GFP in the nAChR open reading frame of 4-GFP, 2-GFP, and
3-GFP mice was previously described (Nashmi et al., 2003, 2007; Dre-
nan et al., 2008a; Srinivasan et al., 2011). nAChR exon/intron structure is
relatively conserved for the genes under study in this paper, and the
coding sequence for the M3-M4 loop is contained within exon 5 of the
nAChR genes we manipulated. For each nAChR gene, a targeting vector
was constructed containing exon 5 with GFP fused in-frame in the de-
sired position in theM3-M4 loop coding sequence. Several kilobases of 5
and 3 sequence (relative to exon 5) were included to direct homologous
recombination. A neomycin cassette flanked by loxP sites was inserted
adjacent to the modified exon 5 in the targeting vector. A diphtheria
toxin negative selection cassette was inserted adjacent to one of the ho-
mology arms (5 or 3).
Targeting vectors were linearized and electroporated into C57BL/6
embryonic stem cells. G418-resistant cell clones were isolated and ampli-
fied. First, clones were screened via PCR to identify those positive for
both the 5 and 3 homologous recombination events. Next, clones pos-
itive in the 5 and 3 PCR assays were further evaluated for correct ho-
mologous recombination (and the absence of additional genomic
rearrangements) via Southern blot with probes designed to detect both
the 5 and 3 homologous recombination events. At least three positive
ES cell clones were injected into 3.5-d-old embryos (blastocyst stage)
derived from an albino C57BL/6 strain (C57BL/6J-Tyrc-2J/J), and reim-
planted into pseudo-pregnant females and allowed to develop to term.
Progenymales with evidence of high (50%) chimerism (based on black
vs white coat color) were selected for further breeding after reaching
sexual maturity. To both (1) breed chimeras to the F1 generation and (2)
excise the neomycin selection cassette from the genome of the F1 prog-
eny, chimeric males were mated with female C57BL/6 Cre-deleter
(proprietary to genOway)mice. To confirm germline transmission, neo-
excision, and maintenance of the proper homologous recombination
event, F1 mice were genotyped via both PCR and Southern blot. Sum-
marizing, all nAChR subunit GFP mice are extensively backcrossed to
C57BL/6 (6-GFP, 4-GFP) or are fully isogenic with C57BL/6 (3-
GFP, 2-GFP, 3-GFP, and 4-GFP). DNA sequences for all targeting
vectors, Southern blotting probes, and PCR primers are available upon
request.
Chronic nicotine treatment.To treatmice chronically with nicotine and
to study nicotine withdrawal, mice were implanted with primed osmotic
minipumps (model 2004; Alzet) filled with sterile saline or ()-nicotine
hydrogen-tartrate salt dissolved in sterile saline. Nicotine (free base) was
delivered at a rate of 1 mg/kg/h for 14 d. On day 14, minipumps were
surgically removed, and mice were killed 18–24 h later for electrophysi-
ology experiments. Alternatively, on day 14 after implantation, some
mice were injected intrapertoneally with mecamylamine (1 mg/kg) to
precipitate withdrawal. Mice were transcardially perfused 90 min after
mecamylamine injection, brains were removed, sectioned (50m thick-
ness), and stained with anti-c-Fos antibodies as described below.
Immunohistochemistry. For analysis of nAChR-GFP expression in
mouse brain, mice under deep anesthesia were perfused transcardially
with cold PBS followed by cold PBS containing 4% PFA. Brains were
postfixed overnight in 4% PFA in PBS. Using MultiBrain Technology
(NeuroScience Associates), nAChR-GFP brains were embedded in a gel-
atin matrix. After freezing the brain samples to70°C with dry ice, they
were sliced coronally into 35-m-thick serial sections using a mi-
crotome. For anti-GFP staining, the following procedures were followed.
Sections were washed 3 times for 5 min per wash in TBS, followed by
incubation in peroxide solution (0.9% H2O2 in TBST, which is TBS
containing 0.3% Triton X-100) for 30 min. Sections were rinsed 3 times
for 5 min per wash in TBS, followed by incubation in blocking serum
(normal horse serum diluted 80 into TBST) for 60 min. Sections were
rinsed 3 times for 5 min per wash in TBS, followed by incubation in
primary antibody solution (rabbit anti-GFP; 1:5000; Millipore) over-
night at room temperature. Sections were washed 3 times for 5 min per
wash in TBS, followed by incubation in solution containing biotinylated
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secondary antibodies (goat anti-rabbit biotinylated IgG; 1:240; Vector
Laboratories) for 60 min. Sections were washed 3 times for 5 min per
wash in TBS, followed by incubation in ABC solution (TBST containing
Reagent A and B solutions, VECTASTAIN Elite ABC System; Vector
Laboratories) for 120 min. Sections were washed 3 times for 5 min per
wash, followed by incubation for 0–10 min in DAB-H2O2 solution
(0.00017%DABdiluted into TBST containing 0.0015%H2O2) with con-
tinuous visualmonitoring ofDAB staining. Sectionswerewashed 2 times
for 5 min per wash, placed in fresh TBS, mounted onto glass slides, and
coverslipped.
Some sections cut by NeuroScience Associates were stained at Purdue
and imaged with confocal microscopy. For those, as well as c-Fos stain-
Figure 1. Production of GFP-labeled nAChR subunits. A, Functional characterization of3-GFP and4-GFP subunits. mRNA encodingWT or GFP-fused mouse3 and4 nAChR subunits was
transcribed andmicroinjected (ratio of 2 subunits:3 subunits) intoX. laevisoocytes. Using two-electrode voltage clamp (holdingpotential60mV), inward current responseswere recorded
during application of ACh at the indicated concentrations. Concentration-response curves were constructed, and data were fitted to the Hill equation. The number of oocytes analyzed was 11 (WT
34), 11 (3GFP4), and 7 (34GFP). B, The nAChR genes modified and/or reported on in this study are the following:3,4,6,2,3, and4. For each of these genes, the M3–M4
intracellular loop is the site for insertion ofmonomeric GFP (abbreviated simply as “GFP”) and is encoded by exon 5. Except for the6-GFP strain, for each of these nAChR subunit genes, a targeting
vectorwas built that contained amodified (GFP inserted in-frame) exon 5, a neomycin selection cassette flanked by loxP sites, several kilobases of homologous 5 and 3 sequence (homology arms),
and a diphtheria toxin-negative selection cassette. Targeting vectors were linearized and electroporated into mouse embryonic stem cells. GFP insertion into exon 5 was verified as described in
Materials and Methods, targeted ES cell clones were injected into blastocysts, and blastocysts were implanted into pseudopregnant surrogates. Chimeric mice were crossed to Cre-deleter mice to
remove the neomycin selection cassette in vivo, and correct gene targeting in neo-excised, F1 progeny was analyzed and verified.
Figure 2. Localization of GFP-fused nAChR subunits in mouse brain. A, Brain atlas diagram for five bregma coordinates (bregma 2 mm, 1 mm,1 mm,3 mm,4 mm) corresponding to
approximate bregma coordinates for data presented in B–E. B–E, Brains from six mouse strains expressing GFP-fused nAChR subunits were fixed, sectioned at 35M, and stained with anti-GFP
antibodies. B, C57BL/6 WT brains were processed as a staining negative control. A representative (of n 3) image of a coronal section is shown for each nAChR-GFP mouse strain at the indicated
anterior/posterior coordinate.4 and2 (C),3 and4 (D), and6 and3 (E) were grouped together based on their coexpression in several brain areas.
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ing, the following procedures were followed.
Sections were collected into 12-well tissue cul-
ture plates, washed 3 times for 10min per wash
in TBS, and blocked for 30 min in TBST con-
taining 10% normal horse serum. Sections
were washed 3 times for 10 min per wash and
incubated in a solution containing TBST and
primary antibodies (rabbit anti-GFP; 1:500;
Invitrogen; rabbit anti-c-Fos; 1:400; Santa
Cruz Biotechnology; and goat anti-ChAT;
1:100; Millipore) overnight at 4°C. Sections
were washed 3 times for 10 min per wash in
TBST and incubated in a solution containing
secondary antibodies (chicken anti-rabbit Al-
exa-488; 1:500; Invitrogen; and/or donkey
anti-goat Alexa-555; 1:500; Invitrogen) for 1–2
h at room temperature. Sections were then
rinsed 3 times for 10 min per rinse, mounted
onto glass slides, and coverslipped for confocal
microscopy.
To test for colocalization of recorded neu-
rons with ChAT, brain slices with neurobiotin-
filled neurons were fixed overnight in 4% PFA
in PBS and processed essentially as described
above for confocal microscopy but with the
followingmodifications. Sections were washed
2 times for 10 min per wash in PBS, blocked,
and permeabilized in PBS containing 10%nor-
mal horse serum, 2% BSA and 0.3% Triton
X-100 (PBST) for 60 min. Sections were incu-
bated with PBST solutions containing primary
antibody (goat anti-ChAT; 1:500; Millipore
and streptavidin conjugatedAlexa-488; 1:1000;
Invitrogen) overnight at 4°C. Sections were
washed 3 times for 5 min per wash with PBS,
followed by incubation in PBST solutions con-
taining secondary antibodies (Alexa-555 donkey-anti-goat; 1:500; Invit-
rogen) for 120min at room temperature. Finally, sections were washed 3
times for 10 min per wash with PBS, mounted with anti-fade mounting
medium (Vectashield; Vector Laboratories), and coverslipped.
Brain slice preparation for electrophysiology. Two- to 3-month-old
C57BL/6J mice (The Jackson Laboratory) and 4 knock-out (KO) mice
of either sex were used in accordance with the guidelines of the National
Institutes of Health Office of Laboratory AnimalWelfare, and the proto-
cols were approved by the Institutional Animal Care andUse Committee
at Purdue University. Mice were anesthetized by intraperitoneal injec-
tion of a sodium pentobarbital (200 mg/kg), followed by transcardiac
perfusion with oxygenated (95% O2/5% CO2) N-methyl-D-glucamine
(NMDG) recovery solution (in mM: 93 NMDG, 2.5 KCl, 1.2 NaH2PO4,
30 NaHCO3, 20 HEPES, 25 glucose, 5 Na
 ascorbate, 2 thiourea, 3 Na
pyruvate, 10MgSO4  7H2O, 0.5 CaCl2  2H2O, with pH adjusted to 7.3–
7.4, 300–310 mOsm). The brain was quickly removed into ice-cold
NMDG recovery solution for 1 min, and 200-m-thick coronal slices
containing MHb or IPN were cut with a vibrating microslicer (DTK-
Zero 1; Ted Pella). Coordinates were as follows: (MHb: 1.9 anterior/
posterior, 0.25 lateral,2.5 dorsal/ventral; IPN:3.5 anterior/posterior,
0.0 lateral,4.5 dorsal/ventral). Slices were then incubated in this solu-
tion at 33°C for 12 min, after which they were kept at room temperature
for at least 1 h in 95%O2/5%CO2-equilibratedHEPES-holding-solution
containing the following (in mM): NaCl 92, KCl 2.5, NaH2PO4 1.2,
NaHCO3 30, HEPES 20, glucose 25, Na
 ascorbate 5, thiourea 2, Na
pyruvate 3, MgSO4  7H2O 2, and CaCl2  2H2O 2.
Patch-clamp electrophysiology. Recordings were made under an up-
right microscope (Nikon Eclipse FN-1) equipped with infrared differen-
tial interference contrast optics for visualization. Slices were transferred
to a recording chamber superfused with standard recording ACSF con-
taining (in mM) NaCl 124, KCl 2.5, NaH2PO4 1.2, NaHCO3 24, glucose
12.5,MgSO4  7H2O2, andCaCl2  2H2O2, adjusted to pH7.3–7.4, 300–
310 mOsm. Recordings were performed at 32°C. Patch pipettes were
made from borosilicate glass capillary tubing (1B150F-4; World Preci-
sion Instruments) using amicropipette puller (P-97; Sutter Instrument).
The internal recording pipette solution contained the following (inmM):
K gluconate 135, EGTA 5, HEPES 10,MgATP 2, NaGTP 0.1, CaCl2 0.5,
MgCl2 2; pH adjusted to 7.3with Tris base. In a subset of experiments, 2.5
mg/ml neurobiotin (Vector Laboratories) was added to the internal so-
lution for intracellular labeling of recorded neurons, and the pH was
readjusted. Currents were recorded using aMulticlamp 700B or an Axo-
patch 200B amplifier with a DigiData 1440A interface and Clampex 10.3
software (Molecular Devices) sampled at 5 kHz and low-pass filtered at 1
kHz. Series resistance was uncompensated.
For some drug applications, CNQX (10M), picrotoxin (100M), and
atropine (1 M) were added to the superfusion ACSF by dilution of a
stock solution. Functional AMPAR and nAChR responses were exam-
ined as previously described (Engle et al., 2012, 2013). Briefly, a drug-
filled glass pipette, identical to a typical recording pipette, was connected
to a micropressure ejection system (PV-820 Pneumatic PicoPump;
World Precision Instruments). Ejection pipettes were moved to within
20–40 m of the recorded cell using a piezoelectric manipulator (PA-
100/12; Piezosystem Jena), drug was applied for 250 ms (12 psi), and the
ejection pipette was retracted.
Statistics and data analysis. Summary data are presented in the text and
figures as the mean  SEM t tests (unpaired or paired, as indicated in
figure legends) were used for all comparisons. All statistical tests were
performed using Graphpad software (Prism). Concentration-response
data were fitted to the Hill equation. Differences were considered signif-
icant at p	 0.05.
Results
We previously verified that XFP-tagged 4 (Nashmi et al., 2003,
2007), 2 (Nashmi et al., 2003), 6 (Drenan et al., 2008a; Xiao et
al., 2009, 2011;Mackey et al., 2012), and3 (Drenan et al., 2008a)
subunits are functional in cell expression systems and in vivo in
Figure 3. Localization of GFP-fused nAChR subunits inMHb. A, Brain atlas diagram for three bregma coordinates (bregma1
mm,1.5mm, and2mm) corresponding to anterior, medial, and posterior MHb (orange).B–E, Brains from sixmouse strains
expressing GFP-fused nAChR subunits were fixed, sectioned at 35M, and immunostained with anti-GFP antibodies. B, C57BL/6
WT brainswere processed as a staining negative control. A representative (of n 3) image of anMHb coronal section is shown for
each nAChR-GFPmouse strain at the indicated anterior/posterior coordinate.4 and2 (C),3 and4 (D), and6 and3 (E)
were grouped together based on coexpression in MHb and/or other brain areas.
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some cases, but we have not previously demonstrated the same
for 3-GFP and 4-GFP subunits. To verify that these latter sub-
units are indeed functional, mRNA for 3-GFP and 4-GFP
nAChR subunits was transcribed andmicroinjected intoX. laevis
oocytes. To mimic expression of these GFP-labeled subunits in
the knock-in mice, 3-GFP was expressed withWT 4 subunits,
and 4-GFP was expressed with WT 3 subunits. WT 34 re-
ceptor function was compared as a reference. ACh was applied to
voltage-clamped oocytes for 1 s, and peak current responses were
measured.Mean data ( SEM)were plotted and fitted to theHill
equation for WT 34, 3-GFP4, and 34-GFP nAChRs.
Both 3-GFP and 4-GFP subunits supported relatively normal
nAChR function compared with WT 34 nAChRs (Fig. 1A).
3-GFP4 and 34-GFP nAChRs had ACh EC50 values of 92
M (95% confidence interval: 81–105 M) and 262 M (95%
confidence interval: 246–279 M) and Hill coefficients of 1.6 
0.1 and 1.8 0.1, respectively. ReferenceWT 34 nAChRs had
an ACh EC50 value of 125M (95% confidence interval: 113–137
M) and a Hill coefficient of 1.6 0.1, consistent with previous
studies on this receptor (Fig. 1A) (Drenan et al., 2008a). We seek
to make exon-replacement knock-in mice with a particular
nAChR-GFP mutation only when the mutation is expected to
result in a change in sensitivity of approx-
imately twofold or less compared with
the WT subunit. Although 34-GFP
nAChRs did exhibit a slight reduction in
sensitivity compared with WT 34
nAChRs in oocyte experiments (Fig. 1A),
the change was approximately twofold in
magnitude, so we proceeded with this
GFP insertion to make 4-GFP mice.
For each of the 3, 4, 2, 3, and 4
nAChR genes, an exon replacement strat-
egy in embryonic stem cells was used to
insert an enhanced GFP sequence in-
frame into exon 5 of the nAChR gene (Fig.
1B). This resulted in production of
nAChR subunits with an intervening,
functional GFP protein within the large,
M3-M4 intracellular loop. In addition to
these 5 new knock-in mouse strains, we
also used BAC transgenic mice expressing
GFP-fused 6 nAChR subunits, which
have been reported previously (Mackey et
al., 2012). nAChR-GFP mice were per-
fused and coronal sections were cut at 35
M from bregma 2 mm to 4 mm (Fig.
2A). Sections were stained with anti-GFP
antibodies and visualizedwithDABhisto-
chemistry. Figure 2B–E shows representa-
tive images of GFP-stained coronal
sections for all GFP mice (and C57BL/6
WT control mice; Fig. 2B) at 5 different
anterior/posterior coordinates (bregma 2,
1,1,3, and4mm) corresponding to
sites of known expression for these sub-
units. Subunits were grouped based on
similar localization patterns in the brain:
4 and 2 (Fig. 2C), 3 and 4 (Fig. 2D),
and 6 and 3 (Fig. 2E). Based on known
localization patterns using methods, such
as radioligand binding and mRNA in situ
hybridization, no aberrant localization of
GFP-labeled subunits was apparent in our staining results (Fig.
2B–E). 4 and 2 subunits were distributed throughout the
brain, including but not limited to cerebral cortex, striatum, thal-
amus (including dorsal lateral geniculate nucleus), MHb, sub-
stantia nigra (SN), ventral tegmental area (VTA), and superior
colliculus (SC) (Fig. 2C). 3 and 4 distribution was apparent in
piriform cortex, MHb, fasciculus retroflexus (FR), and IPN, with
additional 3 found apparent in SC (Fig. 2D). 6 was found at
low levels in prefrontal cortex and striatum,MHb, SN, VTA, and
SC (Fig. 2E). 3, which has been difficult to localize in the brain
because it does not participate in a nAChR agonist binding site
(Drenan et al., 2008a), has moderate levels in cortical areas, ST,
MHb, FR, SN, VTA, and SC (Fig. 2E).
To analyze nAChR localization in the MHb to IPN pathway,
sections containing MHb (bregma 1 to 2 mm; Fig. 3A) and
IPN (bregma3.2 to3.9 mm; Fig. 4A) were stained with anti-
GFP primary antibodies and peroxidase-conjugated secondary
antibodies, followed by visualization with a DAB reaction. Ter-
minology for MHb subnuclei follows a recent study (Aizawa et
al., 2012). 4, 2, and 4 nAChR subunits are restricted to the
ventral two-thirds of the MHb (referred to as MHbV) (Fig.
3C,D). 3, 6, and 3 subunits are also largely restricted to the
Figure4. LocalizationofGFP-fusednAChR subunits in IPN.A, Brain atlas diagram for 3bregmacoordinates (bregma3.2mm,
3.5mm, and3.9mm) corresponding to anterior, medial, and posterior interpeduncular nucleus.B–E, Brains from sixmouse
strains expressing GFP-fused nAChR subunits were fixed, sectioned at 35M, and immunostained with anti-GFP antibodies. B,
C57BL/6 WT brains were processed as a staining negative control. A representative (of n 3) image of an IPN coronal section is
shown for each nAChR-GFP mouse strain at the indicated anterior/posterior coordinate.4 and2 (C),3 and4 (D), and6
and3 (E) were grouped together based on coexpression in MHb and/or other brain areas.
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MHbV, but immunoreactivity for these
subunits is also evident in a small number
of cells in the dorsal one-third of MHb
(MHbD) (Fig. 3D,E). 3 and 4 subunit
localization is even and strong throughout
the MHbV, with subunits also evident in
efferent fibers that give rise to the FR (Fig.
3D). 4 subunits are exclusively found in
the lateral portion of the MHbV (referred
to as MHbVL) (Fig. 3C), consistent with
previous reports (Nashmi et al., 2007;
Fonck et al., 2009). In contrast to 4, 6
subunits are mainly found in the inferior
portion of MHbV (MHbVI), with addi-
tional faint expression in the lateral por-
tion of MHbD (Fig. 3E). 2 subunit
immunoreactivity is seen throughout
MHbV, with preference for central and
inferior MHbV (Fig. 3C). 3 subunits are
strong in MHbVI and MHbVC but very
weak in MHbVL (Fig. 3E).
Next, nAChR subunit localization was
analyzed in IPN from bregma 3.2 to
3.9 mm (Fig. 4A) using anti-GFP im-
munohistochemistry in C57BL/6 WT
(Fig. 4B) and nAChR-GFP knock-in mice
(Fig. 4C–E). Terminology used for IPN
subnuclei is consistent with Wada et al.
(1989) and the mouse brain atlas (Frank-
lin and Paxinos, 2008): rostral subnucleus
(IPR), dorsomedial subnucleus (IPDM),
dorsolateral subnucleus (IPDL), caudal
subnucleus (IPC), and intermediate sub-
nucleus (IPI). Similar to MHb, 3 and 4
subunit levels are strong in IPR, IPDM,
IPDL, IPC, and IPI, with moderate
amounts of subunits also evident in IPL
and IPDL (Fig. 4D). 4 subunits are
strongest in IPR and IPDM, with lower
levels of immunoreactivity evident in IPC
and IPI (Fig. 4C). In contrast to 4, 6
subunits are found at low levels in ventral
IPR and IPC with little to no 6 subunits
found in dorsal IPR or IPDM (Fig. 4E).2
subunit levels are modest throughout the
rostral IPN but are restricted to IPC and
IPI in caudal IPN (Fig. 4C). 3 levels are
strong in most IPN subnuclei but were
not found in dorsal IPR and/or IPDM
(Fig. 4E).
The MHbV stains positive for cholin-
ergic markers, such as ChAT and VAChT
(Contestabile et al., 1987), and IPN nAChRs in presynaptic ter-
minals fromMHbV neurons are involved in ACh release (Grady
et al., 2009).However, other reports indicate thatMHbVneurons
are glutamatergic and that nAChRs in presynaptic terminals in
IPN are involved in regulating glutamate release (Ren et al., 2011;
Hu et al., 2012). Using mouse strains expressing GFP-labeled
nAChRs, we costained brain sections containingMHb with anti-
GFP and anti-ChATprimary antibodies. TheMHbwas imaged at
60 magnification using confocal microscopy. Anti-GFP stain-
ing recapitulated our DAB staining results with respect to ana-
tomical specificity; 3 and 4 subunits were found throughout
theMHbV,4was restricted toMHbVL,6was largely restricted
toMHbVI plus theMHbDC, and2 and3 subunits were found
in MHbVI and MHbVC (Fig. 5A). All subunits were found in
some/many ChAT() MHbV neurons, but we also found evi-
dence for 3, 4, and 6 subunits localized to ChAT() cells
(Fig. 5A). In contrast, nearly all cells that were immunoreactive
for 2, 3, and 4 subunits were also ChAT() (Fig. 5B).
We were interested to further explore the possibility that
ChAT() cells contained functional nAChRs, so we studied
MHbVneurons and nAChR function using patch-clamp electro-
physiology in brain slices from C57BL/6 mice. First, we devel-
Figure 5. nAChR MHb localization and function in ChAT() and ChAT() cells. A, For3-GFP,4-GFP, and6-GFP mouse
strains, coronal MHb sections were prepared, double-stainedwith anti-GFP and anti-ChAT antibodies, and imaged using confocal
microscopy.Merged (green represents anti-GFP; red represents anti-ChAT; yellow represents colocalizedpixels)micrographsof the
MHb (top panels), and a high-resolution zoom of several cells in MHb (bottom panels) are shown. Single, diagonal arrowheads
indicate cells expressing both ChAT and the nAChR-GFP subunit. Double, horizontal arrowheads indicate cells expressing nAChR-
GFP subunits but not ChAT. Scale bars: top, 50m; bottom, 10m. B, For2-GFP,3-GFP, and4-GFPmouse strains, coronal
MHb sections were prepared, double-stained with anti-GFP and anti-ChAT antibodies, and imaged using confocal microscopy.
Merged (green represents anti-GFP; red represents anti-ChAT; yellow represents colocalized pixels) micrographs of the MHb (top
panels), and a high-resolution zoomof several cells inMHb (bottompanels) are shown. Single, diagonal arrowheads indicate cells
expressing both ChAT and the nAChR-GFP subunit. Double, horizontal arrowheads indicate cells expressing nAChR-GFP subunits
but not ChAT. Scale bars: top, 50m; bottom, 10m. C, Action potential firing patterns in MHb versus LHb neurons. Coronal
habenular brain sliceswere prepared fromC57BL/6WTmice, and cell-attached recordingsweremade fromMHband LHbneurons.
A representative trace is shown from a typical cell-attached recording from aMHb and LHb neuron.D, In whole-cell configuration,
action potential firing in response to hyperpolarizing current (50 pA) injections was recorded in MHb and LHb neurons. Repre-
sentative traces show the latency to recovery of action potential firing, as well as the action potential firing frequency, after
cessation of current injection. E, Responses to nicotine puffs in ChAT() and ChAT() MHb neurons. MHb neuronswere voltage-
clamped at60mV, and nicotine (30M, 250ms) was puff-applied to the cell using a Picopump. Representative inward current
deflections are shown for applications of nicotine at the indicated concentration. Responses fromChAT() and ChAT() neurons
are shown. ChAT expressionwas later determined and assigned to each cell with a nicotine puff response as described in F. F, ChAT
expression inMHb cells. For cells studied in E, neurobiotinwas included in the patch pipette internal solution tomark the recorded
cell. After successful nicotine puff experiments, neurobiotin-filled cells in slices were recovered and double-stained with
streptavidin-Alexa-488 conjugates and anti-ChAT antibodies. A representative ChAT() and ChAT() MHb neuron that was
studied with nicotine puffs is shown. Thewidemicrograph shows the location of the cell in theMHb. Inset showswhether the cell
was ChAT () (yellow color) or ChAT () (green color). Scale bars: 50m; inset, 10m.
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oped the ability to distinguishMHb neurons fromneurons in the
adjacent lateral Hb (LHb).WhereasMHb neurons exhibited reg-
ular, tonic firing when action potentials were recorded in cell-
attached recordings (Fig. 5C), LHb neurons were heterogeneous,
frequently exhibiting phasic bursts of spontaneous action potentials
followed by periods of inactivity (Fig. 5C). Further, “anode break”
excitation differed between MHb and LHb neurons: in whole-cell
mode, MHb neurons exhibited single action potentials following a
brief hyperpolarizing current injection (anode break action poten-
tials; Fig. 5D). In contrast, LHb neurons exhibited multiple low-
amplitude anode break action potentials (Fig. 5D). The latency to
actionpotential firing during anode breakwas often, but not always,
shorter in LHb cells versusMHb cells (Fig. 5D).
Having established criteria to distinguish MHb from LHb
neurons, we next recorded inward currents in response to nico-
tine in ChAT() and ChAT() neurons. For both ChAT()
andChAT() cells, we recorded robust responses to nicotine (30
M) (Fig. 5E). Cells displaying nicotine-elicited inward currents
were verified as ChAT() orChAT() by
filling with neurobiotin, double-staining
with streptavidin-Alexa-488 conjugate and
anti-ChAT antibodies, and confocal
imaging. Representative ChAT() and
ChAT() cells displaying nicotine-
elicited inward currents are shown (Fig.
5F). These results suggest that nAChR
function is not restricted to ChAT()
cells inMHbV. Neurons studied in subse-
quent recordings reported belowwere not
analyzed for ChAT expression status.
Based on differences in localization of
nAChR subunits within regions ofMHbV
(Fig. 3), evidence for nAChRs in both
ChAT() and ChAT() cells (Fig. 5),
and emerging data showing specific gene
expression in certainMHb to IPN circuits
(Aizawa et al., 2012), we focused on dis-
tinguishing neurons within theMHbV re-
gion. In particular, we recorded from
MHbVL and MHbVC neurons (Fig. 6A).
In the cell-attached configuration, spon-
taneous action potential firing rates were
similar in MHbVL and MHbVC neurons
(MHbVL  4.3  0.5 Hz, MHbVC 
5.0 0.6 Hz; unpaired t test, p 0.208).
In whole-cell configuration, MHbVL and
MHbVC neurons had a similar resting
membrane potential when pipettes were
filled with a K-gluconate-based internal
pipette solution (MHbVL42.2 1.7
mV, MHbVC  42.6  1.7 mV; un-
paired t test, p  0.429). In a measure of
cellular excitability, we measured spike
amplitude after a prolonged (1000 ms),
depolarizing (50 pA) current injection
(i.e., adaptation ratio) (Fig. 6F) (Bugay-
sen et al., 2010). MHbVL neurons exhib-
ited significantly more decline in spike
amplitude after depolarizing current in-
jection compared with MHbVC neurons
(Fig. 6G).
Tonic, spontaneous action potential
firing (Fig. 5C) suggested that MHbV
neurons may express hyperpolarization-activated inward cation
current (Ih current). Both MHbVL and MHbVC neurons exhib-
ited small but detectable Ih current in response to hyperpolariza-
tion (Fig. 6B), with MHbVC neurons exhibiting significantly
more Ih current thanMHbVLneurons (Fig. 6C). Differences in Ih
current in MHbVL and MHbVC neurons suggested that these
cells may respond differentially after hyperpolarizing current
pulses. To test this idea, MHbVL and MHbVC neurons in
current-clamp mode were briefly (100 ms) injected with hyper-
polarizing (75 pA) current pulses, and the delay from the end of
the pulse to the first action potential (i.e., rebound delay) was
measured (Fig. 6D). MHbVL neurons exhibited a significantly
longer rebound delay compared withMHbVCneurons (Fig. 6E),
consistent with the idea that Ih currents activated during the hy-
perpolarizing pulse help to depolarize the neuron, allowing it to
reach threshold more quickly.
Next, we used linear regression analysis and tested whether
two of the electrophysiological parameters we recordedwere cor-
Figure 6. Electrophysiological properties of MHbVL and MHbVC neurons. A, Diagram of approximate location of MHbVL and
MHbVC. B, Hyperpolarization-activated cation currents (Ih) in MHbVC and MHbVL. MHb neurons were voltage-clamped at60
mV, and the command voltagewas pulsed to120mV for 1 s. The amplitude of the voltage-dependent inward current response
was measured beginning with the current value at the end of the capacitive transient (indicated by the broken line), ending with
the current value at the endof the voltage step. Representative Ih current traces are shown forMHbVLandMHbVC cells. Calibration:
100 pA, 200ms. C, Quantification of Ih currents. A bar graph is shown for all recordedMHbVC (n 13) andMHbVL (n 18) cells.
**p	 0.01 (unpaired t test). D, Measurement of rebound (anode break) delay in MHbVC and MHbVL neurons. MHb neurons
recorded in whole-cell configuration were current-clamped (I 0), followed by injection of hyperpolarizing (75 pA) current.
The latency to firinganactionpotential after the endof thepulse (fromthebroken line to thearrowhead)wasmeasured forMHbVC
and MHbVL neurons. Representative current traces are shown for MHbVL and MHbVC cells. Calibration: 50 mV, 200 ms. E, Quan-
tification of rebound delay responses. A bar graph is shown for all responses fromMHbVL (n 18) andMHbVC (n 13) neurons.
**p	 0.01 (unpaired t test). F, Action potential amplitude adaptation inMHb neurons.MHb neuronswere current-clamped (I
0), and depolarizing current (50 pA)was injected. The amplitude of the first and last spike in the trainwasmeasured (between the
twobroken lines), and the adaptation ratio (last spike amplitude/first spike amplitude)was calculated for each cell. Calibration: 50
mV, 200 ms. G, Quantification of adaptation ratio measurements from F. A bar graph is shown for all adaptation ratio responses from
MHbVL (n 18) and MHbVC (n 13) cells. **p	 0.01 (unpaired t test). H, J, For each recorded MHbVL (H; black open circles) and
MHbVC (J; red open circles) neuron, Ih current amplitude was plotted on the x-axis, and rebound delay was plotted on the y-axis. Linear
regressionanalysiswasperformedon theplotteddatapoints, and r 2 andpvalues are shown. I,K, For each recordedMHbVL (I; blackopen
circles) andMHbVC (K; red open circles) neuron, Ih current amplitudewas plotted on the x-axis, and adaptation ratio was plotted on the
y-axis. Linear regression analysiswas performedon the plotted data points, and r and p values are shown.
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related with expression of Ih current. In both MHbVL and
MHbVC neurons, Ih current amplitude (atVm120mV) was
anti-correlatedwith rebounddelay (Fig. 6H, J). Similarly, in both
MHbVL and MHbVC neurons, Ih current was positively corre-
lated with adaptation ratio (Fig. 6 I,K) (Bugaysen et al., 2010).
These results, in addition to revealing differences between
MHbVL andMHbVC neurons, indicate that Ih current may play
a general role in shaping the excitability of MHbV neurons.
Based on differences in nAChR subunit localization between
MHbVL and MHbVC neurons (Fig. 3), and in part due to our
results showing differences in excitability between these two re-
gions of MHbV (Fig. 6), we next studied nAChR function in
MHbVL and MHbVC cells using puff-application of nicotine.
MHbVL andMHbVC neurons were recorded in whole-cell con-
figuration. Neurons were voltage-clamped at60 mV and nico-
tine was puff-applied using a second drug-filled pipette
positioned 20–40m from the recorded cell. Interestingly, MH-
bVL neurons exhibited small but detectable responses to 1 M
nicotine (Fig. 7A,B). MHbVC neurons, on the other hand, did
not respond appreciably to this concentration of nicotine (Fig.
7A,B,D). Both MHbVL and MHbVC neurons responded with
inward currents following puff-application of 30 M nicotine,
but mean responses in MHbVL neurons were, again, larger than
in MHbVC neurons (Fig. 7C,D).
Although nicotine typically achieves concentrations of 50–
200 nM in the CSF of smokers, concentrations of nicotine as high
as 1Mhave been reported as well (Malkawi et al., 2009). Because
nAChRs in MHbVL neurons are sensitive to 1 M nicotine, we
tested the idea that MHbVL neurons would respond to pro-
longed (
10 min) exposure to 1 M nicotine with altered action
potential firing. Cell-attached recordings were made from
MHbVL andMHbVC neurons, followed by bath application of 1
M nicotine. Whereas MHbVC neurons did not significantly
change their firing in response to 1Mnicotine,MHbVLneurons
exhibited a significant increase in firing rate relative to prenico-
tine baseline firing (Fig. 8A,D,E). Next, we sought to better un-
derstand the mechanism behind this difference in firing after
nicotine application. Results from GFP-nAChR knock-in mice
indicate that one defining factor of MHbVL neurons is their ex-
pression of 4 subunits (Fig. 3). Because 4* nAChRs are among
the most sensitive to nicotine and ACh (Salminen et al., 2004,
2007), we tested the idea thatMHbVL sensitivity to 1Mnicotine
(Fig. 8) required 4 subunits. We measured cell-attached firing
in MHbVL neurons in slices from 4 knock-out mice, and we
found that 1 M nicotine did not significantly increase firing
above baseline levels (Fig. 8B,D,E). Next, because 4 subunit
levels are strong in MHbVL (Fig. 3D), we tested the hypothesis
that 4 subunits play a role in the response to 1 M nicotine in
MHbVL cells. Pretreatment of cells with SR16584, a selective
antagonist of 34* nAChRs, eliminated the increase in action
potential firing rate elicited by 1M nicotine inMHbVL neurons
(Fig. 8C–E). Together, these results point to a role for 4 and 4
subunits, and likely nAChR pentamers containing both of these
subunits, in the response of the MHb/IPN pathway to nicotine.
The MHb to IPN pathway is a key circuit mediating the so-
matic and affective signs of nicotine withdrawal in rodents, and
presumably in humans. To determine whether MHbVL neurons
play a role in nicotine withdrawal, we implanted C57BL/6 WT
mice with osmotic minipumps delivering control saline or nico-
tine (1 mg/kg/h) for 14 d. To elicit withdrawal from nicotine,
minipumps were removed, and brain slices were prepared for
electrophysiology 18–24 h later (Fig. 9A). First, we measured
nicotine-evoked currents using puff-application of 1 and 30 M
nicotine. Compared with saline-withdrawn mice, there was a
trend toward a decrease in nicotine-evoked currents in MHbVL
neurons from nicotine-withdrawn mice at 1 M nicotine (Fig.
9B,C). Furthermore, there was a significant reduction in
nicotine-evoked current amplitudes in nicotine-withdrawn
MHbVL neurons at 30 M nicotine (Fig. 9B,D). Next, we mea-
sured action potential firing in response to nicotine (1 M) reex-
posure inMHbVL neurons fromnicotine- and saline-withdrawn
mice. Consistent with a reduction in nAChR responsiveness seen
in puff-application experiments (Fig. 9D), MHbVL neurons
from nicotine-withdrawn mice exhibited a blunted response to
nicotine application in cell-attached firing experiments (Fig. 9E).
Although raw baseline and nicotine-evoked firing rates in
nicotine- and saline-withdrawn mice were similar (Fig. 9F),
nicotine-withdrawnMHbVL neurons did not respond to 1Mnic-
otine application with as large an increase in firing rate as saline-
withdrawn MHbVL neurons (Fig. 9G). To verify that our
minipump procedure did indeed deliver chronic nicotine to
mice, we conducted a control experiment. Mice implanted with
saline- or nicotine-containing minipumps for 14 d were given an
intraperitoneal injection of mecamylamine (1 mg/kg) to precip-
itate withdrawal from chronic nicotine, and mice were perfused
90min later for immunohistochemical analysis. Coronal sections
containing the IPN were stained for c-Fos induction, and we
noted a large increase in c-Fos-immunoreactive neurons in the
IPN of mecamylamine-injected mice treated with chronic nico-
tine versus mecamylamine-injected mice treated with chronic
saline (Fig. 9H). This result parallels a recent result obtained by
Tapper and colleagues, who demonstrated that nicotine with-
drawal results in activation of GABAergic neurons in the IPN
(Zhao-Shea et al., 2013).
Figure 7. Nicotine-elicited inward currents in MHbV neurons. A, MHbVL or MHbVC neurons
were voltage-clamped at 60 mV, and nicotine at the indicated concentration was puff-
applied. Representative traces are shown for each nicotine concentration and cell type. Calibra-
tion: 1M nicotine, 25 pA, 5 s; 30M nicotine, 0.5 nA, 5 s. B, Mean nicotine (1M) responses
from MHbVL (n 7) and MHbVC (n 8) neurons are shown. *p	 0.05 (unpaired t test). C,
Meannicotine (30M) responses fromMHbVL (n7) andMHbVC (n7) neurons are shown.
*p	 0.05 (unpaired t test). D, Data from B and C are plotted together on a logarithmic scale.
*p	 0.05 (unpaired t test).
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To further study MHbVL to IPN circuitry, we recorded from
IPN neurons in the IPR and IPDM. These areas, according to our
immunohistochemistry data (Fig. 4), display high and specific
expression of 4 nAChR subunits that largely originate in
MHbVL. IPR/IPDM neurons were recorded in whole-cell con-
figuration, first in current-clamp mode. Most IPR/IPDM neu-
rons recorded from (19 of 25) did not fire spontaneously, and had
an average restingmembrane potential of62 1mV. Interest-
ingly, when positive current was injected during current-clamp
recordings, two responses were evident. One class of cells was less
sensitive to current injection, responding to positive current in-
jection with moderate increases in firing (Fig. 10A, left). The
other class of cells (Fig. 10A, right) was comparatively more sen-
sitive to positive current injection and tended to exhibit rapid
(100 Hz) (Fig. 10D), phasic bursts of action potentials (Fig.
10A, right). For subsequent experiments (described below), we
first recorded firing responses in current-clamp mode, and
slower-firing and faster-firing neurons were classified as Type I
and Type II IPR/IPDM neurons, respectively.
MHbneurons express cholinergic and glutamatergicmarkers,
and in optogenetic experiments, appear to use both ACh and
glutamate to signal to IPN neurons (Ren et al., 2011). Thus, we
reasoned that some IPN neurons likely express and use AMPA-
type glutamate receptors (AMPARs). To study AMPARs, we
puff-applied AMPA to IPR/IPDMneurons held in voltage-clamp
mode similar to our previous study (Engle et al., 2013). As with
action potential firing, we found two types of responses to AMPA
that cosegregated with action potential firing in response to positive
current injection. Type I IPR/IPDMneurons exhibited responses to
puffedAMPA (100M) that were relatively small (273.4 30 pA;
Fig. 10B, left), with a slower deactivation time constant of 16.7 3 s.
By contrast, Type II IPR/IPDM neurons were found to have com-
paratively larger (1292.0 116 pA; Fig. 10B, right) responses to
AMPAwith amuchmore rapid deactivation time constant of 5.7
1 s. To determine whether these differences in response to AMPA
were due to greater potency of AMPA or greater efficacy of AMPA,
we studied AMPA concentration-response relations for Type I and
Type II IPR/IPDM neurons. The AMPA concentration-response
data from Type I neurons were fitted (r2 0.60) to a monophasic
function (Fig. 10E), with an EC50 of 30.5 M. Interestingly, AMPA
concentration-response data from Type II neurons fit well (r2 
0.87) to a biphasic function. The higher-sensitivity component had
an EC50 of 3.3M, whereas the lower-sensitivity component had an
EC50of53.7M.Thesedifferences inAMPARfunction inType Iand
Type II IPR/IPDMneurons suggest thatAMPARexpressionmay be
greater inType II IPR/IPDMneurons or that differentAMPARsub-
types are expressed in these two populations.
Our immunohistochemistry data (Fig. 4) suggest a prominent
role for MHb-derived, presynaptic nAChRs in IPN. Our data do
not, however, rule out a postsynaptic role for some nAChR sub-
types in IPN. Several studies suggest a postsynaptic role for
nAChRs in IPN (Wada et al., 1989; Hsu et al., 2013). To study the
action of nicotine on IPR/IPDM neurons and to further char-
acterize Type I and Type II IPR/IPDM neurons, we studied
responses to puffed nicotine. Like firing responses and AMPA-
evoked currents, nicotine-evoked currents exhibited a bimodal
distribution: Type II neurons responded to 10 M nicotine with
larger-amplitude currents compared with Type I neurons (Fig.
10C,F). This difference was also evident in responses to 1 M
nicotine (Fig. 10F). Together, these recordings in two types of
IPR/IPDM neurons reveal interesting differences between these
cell types in excitability and coupling to glutamatergic and cho-
linergic afferents from MHbVL.
Figure 8. 34* and/or 4* nAChRs drive nicotine-elicited firing in MHbVL neurons. A, Cell-attached recordings from MHbVL (n 8) and MHbVC (n 8) neurons were established, and
baseline firing was recorded for several minutes, followed by superfusion of nicotine (1 M). Normalized firing rate is plotted, with baseline firing before nicotine application set to 1.0. B,
Cell-attached recordings from4 KOMHbVL neurons (n 9)were conducted. As inA, baseline firingwas recorded followed by firing in response to superfusion of 1M nicotine. Data fromMHbVL
WT neurons shown in A are replotted for reference using dashed lines and no symbols. C, Cell-attached recordings from WT MHbVL neurons (n 6) were conducted in response to SR16584, a
putative34* nAChR antagonist. Baseline firing was recorded for several minutes, followed by superfusion of SR16584 (20M), then superfusion of nicotine (1M) plus SR16584. Data from
MHbVL WT neurons shown in A (response to 1M nicotine alone) are replotted for reference using dashed lines and no symbols. D, Representative traces from cell-attached firing experiments
described inA–C. A sample current trace from t2.5min (baseline) and t10min (in 1Mnicotine) is shown for the indicated cell type, genotype, and/or pharmacological treatment. Calibration:
20 pA, 200ms. E, Quantification of data shown in A–C. For each cell from each of 4 conditions described in A–C, the fold change in action potential firingwas derived comparedwith predrug firing.
A bar graph is shown for these 4 conditions. *p	 0.05 (paired t test comparing predrug firing and peak firing during drug application for each cell).
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Discussion
nAChR expression inMHb to
IPN pathway
In this study, we used newly developed
nAChR-GFP knock-in mice to localize
nAChR subunits in MHb neurons at sub-
cellular resolution. Our data demonstrat-
ing localization of 3 and 4 subunits
throughout theMHbV area are consistent
with previous reports using antibody
staining or Western blotting (Yeh et al.,
2001; Gahring et al., 2004), radioligand
binding (Salas et al., 2004), mRNA in situ
hybridization (Wada et al., 1989; Winzer-
Serhan and Leslie, 1997;Quik et al., 2000),
and transgenic approaches (Frahm et al.,
2011). Because most previous attempts to
visualize nAChR subunits in MHb or IPN
relied on radioligand binding, 34*
nAChR binding failed to resolve cellular
details of subunit location. Although 4
nAChR subunits were previously local-
ized toMHbVL (Fonck et al., 2009), this is
the first report demonstrating such a spe-
cific pattern for 2, 3, and 6 subunits.
We take particular note that 4, 6,
2, and 3 subunits exhibit a localization
“gradient” across both theMHb and IPN.
4 subunits are confined to MHbVL and,
in IPN, are localized preferentially in IPR
and IPDM (Fig. 11C). Conversely, 6
subunits are confined to MHbVI and ex-
hibit weak but detectable levels in the ven-
tral IPR and in IPC (Fig. 11A). 2 MHbV
localization is somewhat similar to6, be-
ing stronger in MHbVI and weaker in
MHbVC and MHbVL (Fig. 11A–C). 2
IPN localization is largely uniform from
dorsal to ventral but is notably absent
from IPR in caudal IPN sections. Last, 3
subunit levels are strong in MHbVI and
MHbVC (Fig. 11A,B), but comparatively
weaker in MHbVL. In a similar manner,
IPN 3 levels are strong, except in IPDM
and/or dorsal IPR. A gradient pattern for
MHbmolecular markers has been seen by
other investigators. Aizawa et al. (2012)
reported differential expression of mark-
ers in subdivisions of MHb, including
tachykinin 1, vesicular glutamate transporter 1 and 2, the  opi-
oid receptor, and the orphan GPCR Gpr151. Because IPN re-
ceives dense innervations fromMHb via the FR, the patterns seen
for 4, 6, 2, and 3 suggest that specific subdivisions of MHb
project to specific areas in IPN. Our data support previous observa-
tions that MHbVL projects largely to IPR/IPDM, whereas MHbVI
projects preferentially to IPC (Contestabile and Flumerfelt, 1981). If
nAChR activation inMHbVI and/orMHbVL can control neuronal
excitability in these areas, then ligands specific for 4* or 6*
nAChRs could specifically control the activity of cells in IPR/IPDM
or IPC, respectively.
The extremely high density of nAChRs inMHb axons allowed
us to visualize the FR. Interestingly, MHb axons exit the MHb at
two distinct sites, then merge to form the FR. Micrographs of 3
and 4 MHb localization clearly show axons exiting the MHb
from the extreme ventral tip (either MHbVC or MHbVI) as well
as in a more lateral direction from MHbVL (Fig. 3). We termed
these exit sites the “ventral” and “lateral” exit sites. 2 subunit-
containing axons entered the FRprimarily via the ventral exit site,
whereas 4-containing axons entered the FR from the lateral exit
site.3-containing exons entered theFR throughboth exit sites, and
6 subunit levels were too weak to clearly visualize any axons. The
lateral and ventral exit sites that are defined by nAChR subunit con-
tent may correspond to the central and subependymal branches,
respectively, of the medial root of the FR (Andres et al., 1999).
The FR undergoes putative excitotoxic degeneration after ex-
posure to high concentrations of nicotine (Carlson et al., 2000,
Figure 9. nAChR function and nicotine-evoked action potential firing inMHbVL neurons after nicotinewithdrawal.A, Nicotinewith-
drawal procedure. C57BL/6 WT mice were implanted with saline (SAL)- or nicotine (NIC)-containing osmotic minipumps. After 14 d,
minipumpswere removed to initiatewithdrawal, andmicewere killed 1 d later for slice preparation and electrophysiology.B, Represen-
tative traces from nicotine puff-application experiments. The indicated nicotine concentration was puff-applied to MHbVL cells in slices
fromanimals thatunderwentwithdrawal fromchronic salineor chronicnicotine.Calibration:1Mnicotine,10pA,5s;30Mnicotine,0.5
nA,5s.C,Meannicotine(1M)responses fromsaline-withdrawn(n6)andnicotine-withdrawn(n9)MHbVLneuronsareshown.D,
Meannicotine(30M)responsesfromsaline-withdrawn(n6)andnicotine-withdrawn(n8)MHbVLneuronsareshown.**p	0.01
(unpaired t test). E, Time course for cell-attached firing in response to nicotine (1 M) for saline-withdrawn (n 4) and nicotine-
withdrawn(n6)MHbVLneurons.MHbVLneuronswereheld in thecell-attachedconfigurationandactionpotential firingwas recorded
beforeandafterbathapplicationof1Mnicotine.F, Rawfiring frequencies fromexperimentdescribed inE. Baselineandnicotine-elicited
peakactionpotential firing frequency inMHbVLneurons fromsaline-withdrawn (n6) andnicotine-withdrawn (n6)mice is shown.
G, Fold change in action potential firing in response to nicotine. Using raw firing frequency data from F, we calculated the fold change in
actionpotential firing inresponsetonicotineapplication inMHbVLneurons fromsaline-withdrawn(n6)andnicotine-withdrawn(n
6)mice. **p	0.01 (unpaired t test).H, c-Fos induction in IPNneurons aftermecamylamine-precipitatedwithdrawal. C57BL/6WTmice
were implantedwithsaline-ornicotine-containingosmoticminipumpsas inA.Onday14,miceweregivenan injectionofmecamylamine
(1mg/kg, i.p.)andwerekilledandperfused90minlater.Coronal IPNsectionswerestainedwithanti c-Fosantibodies,andarepresentative
image is shown. Scale bars, 30m.
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2001), possibly due to activation of nAChRs that do not strongly
desensitize (Labarca et al., 2001). 44* nAChRs appear to show
reduced desensitization compared with 2* nAChRs (Lax et al.,
2002), and in this studywe have shown evidence for expression of
this subtype inMHbVLneurons. nAChR-GFPmicewill be useful
in future experiments studying the relationship between nAChR
activity and FR degeneration.
Surprisingly, nAChRs were not always seen within ChAT()
neurons. Anti-ChAT staining has been used as a marker for the
MHbV (Fowler et al., 2011; Frahm et al., 2011; Ren et al., 2011),
and optogenetics experiments use the ChAT promoter to direct
expression of channelrhodopsin and to therefore “control”
MHbV activity (Ren et al., 2011; Hu et al., 2012). Most neurons
expressing3,3, and4 subunits were ChAT-immunopositive,
consistent with their role in regulating ACh release in IPN (Grady
et al., 2009). However, 6 and 4 subunits were often found in
neurons that were ChAT(). Future experiments will be re-
quired to determine what neurotransmitters these ChAT()
neurons release and how nAChRs modulate their activity. Be-
cause recordings reported in Figures 6, 7, 8, and 9 are from neu-
rons whose ChAT expression status was not studied, data from
these studies may represent a pool of both ChAT() and
ChAT() neurons.
nAChR function inMHbV neurons
Consistent with a previous (Kim and Chang, 2005) and a more
recent (Go¨rlich et al., 2013) report, we found that some MHb
neurons exhibited spontaneous, tonic action potential firing in
slice preparations. This tonic firing in MHb neurons is likely the
result, at least in part, of expression of HCN channels and
hyperpolarization-activated cation current (Ih) (Go¨rlich et al.,
2013). Although Ih current amplitudes in MHb neurons are
smaller than those seen in SN pars compacta or VTA dopamine
neurons (Engle et al., 2013), our analysis suggests an important
Figure 10. IPR/IPDM neuron populations receiving input fromMHbVL. A, IPR/IPDM neurons recorded in whole-cell configuration were held in current-clamp mode, and action potential firing
was recording while the indicated amount of positive or negative current was injected. Based on the pattern of action potential firing, cells were classified as Type I or Type II. B, Type I or Type II
IPR/IPDMneuronswere voltage-clamped at60mV, andAMPA (100M)was puff-applied. Representative traces are shown for each cell type. Calibration: 300 pA, 2 s. C, Type I or Type II IPR/IPDM
neuronswere voltage-clamped at60mV, and nicotine (10M)was puff-applied. Representative traces are shown for each cell type. Calibration: 100 pA, 2 s.D, Quantification of action potential
firing from A. Action potential firing after injection of the indicated amount of positive current was recorded, and the maximum instantaneous firing rate was derived and plotted for each current
injection. The number of neurons analyzedwas as follows: n 16 (Type I), n 9 (Type II). E, AMPA concentration response relation for Type I and Type II IPR/IPDM neurons. AMPA-evoked inward
currentswere recorded for a rangeofAMPAconcentrations (inM:1, 3, 10, 30, 100, and300).Data fromType Ineuronswere fitted toa single-component function,whereasdata fromType II neurons
were fitted to a biphasic function. The number of Type I neurons analyzed for each AMPA concentration was as follows: n 3 (1M), n 3 (3M), n 7 (10M), n 4 (30M), n 16 (100
M), n 6 (300M). The number of Type II neurons analyzed for each AMPA concentration was as follows: n 2 (1M), n 2 (3M), n 4 (10M), n 3 (30M), n 9 (100M), n 3
(300M). F, Quantification of nicotine-evoked currents in Type I and Type II IPR/IPDM neurons. Cells were voltage-clamped at60mV, nicotine (1 and 10M) was puff-applied, andmean values
are plotted. The number of Type I neurons analyzed for each nicotine concentration was as follows: n 7 (1 M), n 7 (10 M). The number of Type II neurons analyzed for each nicotine
concentration was as follows: n 7 (1M), n 7 (10M). *p	 0.05 (unpaired t test).
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role for Ih in shaping MHb neuron excit-
ability. This is supported by a recent re-
port, which demonstrated that inhibition
of MHb HCN channel activity can elicit
behaviorally relevant changes in IPN ac-
tivity (Go¨rlich et al., 2013). Ih current am-
plitudes in individual cells were positively
correlated with that cell’s ability to fire
sustained and high-frequency trains of ac-
tion potentials, and Ih current amplitude
was negatively correlated with the latency
to anode break firing (Fig. 6). These data
suggest that MHb provides a tonic gluta-
matergic and/or cholinergic signal to IPN
neurons (Grady et al., 2009; Ren et al.,
2011; Hu et al., 2012).
Surprisingly, neurons in MHbVL, but
not MHbVC, were capable of responding
to 1M nicotine with responses similar in
magnitude to those seen in reward-
pathway VTA DA neurons at the same
concentration of nicotine (Tapper et al.,
2004; Drenan et al., 2008b). Furthermore,
1 M nicotine also augmented MHbVL
neuron action potential firing in amanner
similar to that seen in VTA DA neurons
(Liu et al., 2012), and loss of 4 subunits
eliminated this effect (Fig. 8). MHbVC
neurons, which are devoid of4 subunits,
did not express nAChRs that were sensi-
tive enough to 1 M nicotine to elicit in-
ward currents (Fig. 7) or action potential
firing (Fig. 8). Although SR16584 is gen-
erally considered a selective antagonist for
34* nAChRs (Zaveri et al., 2010), it has
not been tested on 44* nAChRs, whose
subunits are found in MHbVL and re-
spond well to 1 M nicotine (Luetje and
Patrick, 1991; Puskar et al., 2011). Our
data also suggest that 34* nAChRs play
a role in the ability of MHbVL to respond
to 1 M nicotine (Fig. 8). Together, these
recordings of action potential firing sug-
gest at least two possibilities: (1) separable
populations of 34* and 4* nAChRs
may mediate nicotine’s action in accelerating
MHbVLneuronfiring;or(2)344*recep-
tors are at least partially responsible for the
increase.
In contrast to 42* nAChRs, 44*
nAChRs are not expected to undergo
marked upregulation in response to
chronic nicotine (Srinivasan et al., 2011). In knock-in mice ex-
pressing YFP-labeled 4 subunits, 4 levels in MHb did not
change significantly in response to chronic nicotine (Nashmi et
al., 2007). Thus, if44* and/or344* nAChRs are expressed
at high levels in MHbVL neurons, it would account for the
blunted response to nicotine in these cells from nicotine-
withdrawn mice (Fig. 9). A recent report corroborated our find-
ings indicating that chronic nicotine reduces MHb neuronal
excitability, although without determining which subregions of
MHbV are involved (Dao et al., 2014). Together, these data sug-
gest that reexposure of MHbVL neurons to nicotine after nico-
tine withdrawalmay result in reduced firing of these neurons and
reduced glutamate and/or ACh release onto IPR/IPDM target
neurons. If IPR/IPDM cells receiving innervation from MHbVL
neurons are GABAergic, as suggested recently (Hsu et al., 2013;
Zhao-Shea et al., 2013), then reexposure to nicotine in nicotine-
withdrawn animals could result in less activation of GABAergic
IPR/IPDM neurons compared with nicotine exposure in control
animals, which could ultimately contribute to relapse because of
a reduction in aversive signals generated by the IPN (Fowler et al.,
2011). Our withdrawal data highlight the importance of studying
subregions of theMHb to IPN pathway, such as theMHbVL, as a
Figure 11. nAChRs and the MHbV to IPN pathway: summary schematic. A, nAChR-expressing cells of the MHbVI project
preferentially to ventral IPN, and the indicated (red text) nAChRsubunits are expressed inMHbsomataand inpresynaptic terminals
in IPN. B, MHbVC projects preferentially to central regions of IPN. C, MHbVL projects preferentially to IPR/IPDM. At least two cell
types exist in IPR/IPDM. Type I neurons exhibit relatively small inward currents in response to puffed nicotine (NIC) and AMPA and
fire tonic action potentials in response to positive current injection. Type II neurons exhibit relatively (compared with Type I cells)
large inward currents in response to puffed NIC or AMPA and fire bursts of action potentials following positive current injection.
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recent study that did not restrict its analysis to specific MHbV
areas found increased nicotine-evoked firing in neurons from
nicotine-withdrawn mice (Go¨rlich et al., 2013). Further, we re-
cently found increased 6 subunit levels in MHbVI of mice
treated chronically with nicotine (Henderson et al., 2014).
Our data reporting electrophysiologically distinct neuronal
populations in IPR/IPDM (Fig. 10C) are novel and build upon
recently published data suggesting the existence of distinct cellu-
lar populations in IPN (Hsu et al., 2013; Zhao-Shea et al., 2013).
Compared with Type I IPR/IPDMneurons, Type II neuronsmay
couple more strongly to cholinergic/glutamatergic input from
MHbVL because of greater function of AMPA receptors (Fig.
10B,E) and a stronger response to nicotine (Fig. 10C,F). Overall,
these studies provide new anatomical and mechanistic details
regarding nAChR expression and function in the brain’s key
aversion pathway.
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